Terms: = Colorectal cancer AND MPL, TPOR, P40238, 4352, ENSG00000117400, CD110, MPLV, C-MPL, RP1-92O14_1 AND Treatment
27217 results:
1. Budget Impact Analysis of Circulating Tumor DNA Testing for Colon cancer in Commercial Health and Medicare Advantage Plans.
Li Y; Heer AK; Sloane HS; Edelstein DL; Tie J; Gibbs P; Barzi A
JAMA Health Forum; 2024 May; 5(5):e241270. PubMed ID: 38819797
[TBL] [Abstract] [Full Text] [Related]
2. [Post-cancer treatment-Related Symptom Distress and Fear of cancer Recurrence in colorectal cancer Survivors].
Gu LS; Lee LY; Huang HY
Hu Li Za Zhi; 2024 Jun; 71(3):52-63. PubMed ID: 38817137
[TBL] [Abstract] [Full Text] [Related]
3. NRS2002 score as a prognostic factor in solid tumors treated with immune checkpoint inhibitor therapy: a real-world evidence analysis.
Tang W; Li C; Huang D; Zhou S; Zheng H; Wang Q; Zhang X; Fu J
Cancer Biol Ther; 2024 Dec; 25(1):2358551. PubMed ID: 38813753
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic Significance of Synchronous colorectal Adenocarcinoma: A Matched-Pair Analysis.
Anannamcharoen S; Nimmanon T; Cheeranont P; Boonya-Ussadorn C
Asian Pac J Cancer Prev; 2024 May; 25(5):1539-1545. PubMed ID: 38809625
[TBL] [Abstract] [Full Text] [Related]
5. PD-1/PD-L1 inhibitors for early and middle stage microsatellite high-instability and stable colorectal cancer: a review.
Wu H; Deng M; Xue D; Guo R; Zhang C; Gao J; Li H
Int J Colorectal Dis; 2024 May; 39(1):83. PubMed ID: 38809459
[TBL] [Abstract] [Full Text] [Related]
6. Temporal dynamics of RAS mutations in circulating tumor DNA in metastatic colorectal cancer: clinical significance of mutation loss during treatment.
Iguchi K; Shiozawa M; Uchiyama M; Asari M; Numata K; Rino Y; Saito A
J Cancer Res Clin Oncol; 2024 May; 150(5):281. PubMed ID: 38805050
[TBL] [Abstract] [Full Text] [Related]
7. Effect of alverine citrate plus simethicone in colonoscopy: a randomized controlled trial.
Wilasrusmee C; Jirasiritham J; Supsamutchai C; Punmeechao P; Poprom N
Sci Rep; 2024 May; 14(1):12035. PubMed ID: 38802518
[TBL] [Abstract] [Full Text] [Related]
8. Total mesorectal excision in MRI-defined low rectal cancer: multicentre study comparing oncological outcomes of robotic, laparoscopic and transanal total mesorectal excision in high-volume centres.
Rutgers ML; Burghgraef TA; Hol JC; Crolla RM; van Geloven NA; Leijtens JW; Polat F; Pronk A; Smits AB; Tuyman JB; Verdaasdonk EG; Sietses C; Consten EC; Hompes R
BJS Open; 2024 May; 8(3):. PubMed ID: 38788679
[TBL] [Abstract] [Full Text] [Related]
9. Characterizing colon lipomas: Insights from a retrospective analysis of clinical presentation and management strategies.
Uygur FA; Kuloğlu E; Aydin G; Muhtaroğlu A; Dülger AC
Medicine (Baltimore); 2024 May; 103(21):e38287. PubMed ID: 38787996
[TBL] [Abstract] [Full Text] [Related]
10. [Advances of CAR-T cell therapy in treating colorectal cancer].
Chao Z; Liu W; Liu Y
Sheng Wu Gong Cheng Xue Bao; 2024 May; 40(5):1365-1379. PubMed ID: 38783803
[TBL] [Abstract] [Full Text] [Related]
11. The nuclear export protein exportin-1 in solid malignant tumours: From biology to clinical trials.
Lai C; Xu L; Dai S
Clin Transl Med; 2024 May; 14(5):e1684. PubMed ID: 38783482
[TBL] [Abstract] [Full Text] [Related]
12. cancer treatment Before and After Physician-Pharmacy Integration.
Kanter GP; Ozluk P; Chi W; Fisch MJ; Debono D; Parikh RB; Jacobson M; Bekelman JE; DeVries A
JAMA Netw Open; 2024 May; 7(5):e2412998. PubMed ID: 38780938
[TBL] [Abstract] [Full Text] [Related]
13. [Epidemiological characteristics of early-onset colorectal cancer: a prospective cohort study from a single center].
Jin T; Zhu YS; Liu CC; Xu X; Lu W; Xiao Q; Ding KF; Zheng S
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 May; 27(5):457-463. PubMed ID: 38778685
[No Abstract] [Full Text] [Related]
14. Baseline characteristics and recruitment for SWOG S1820: altering intake, managing bowel symptoms in survivors of rectal cancer (AIMS-RC).
Sun V; Thomson CA; Crane TE; Arnold KB; Guthrie KA; Freylersythe SG; Braun-Inglis C; Jones L; Carmichael JC; Messick C; Flaherty D; Ambrale S; Cohen SA; Krouse RS
Support Care Cancer; 2024 May; 32(6):371. PubMed ID: 38775966
[TBL] [Abstract] [Full Text] [Related]
15. Integrated analysis of single-cell and bulk RNA sequencing data reveals a myeloid cell-related regulon predicting neoadjuvant immunotherapy response across cancers.
Liu H; Sima X; Xiao B; Gulizeba H; Zhao S; Zhou T; Huang Y
J Transl Med; 2024 May; 22(1):486. PubMed ID: 38773508
[TBL] [Abstract] [Full Text] [Related]
16. Radiotherapy and immunology.
Wang L; Lynch C; Pitroda SP; Piffkó A; Yang K; Huser AK; Liang HL; Weichselbaum RR
J Exp Med; 2024 Jul; 221(7):. PubMed ID: 38771260
[TBL] [Abstract] [Full Text] [Related]
17. A novel perineal exposure method in laparoscopic abdominal perineal resection of rectal cancer: a case series study.
Ma J; Tang D; Tang Y; Wang D; Jiang P; Zhang Y
BMC Surg; 2024 May; 24(1):163. PubMed ID: 38769559
[TBL] [Abstract] [Full Text] [Related]
18. The economic impact of anastomotic leakage after colorectal surgery: a systematic review.
Nijssen DJ; Wienholts K; Postma MJ; Tuynman J; Bemelman WA; Laméris W; Hompes R
Tech Coloproctol; 2024 May; 28(1):55. PubMed ID: 38769231
[TBL] [Abstract] [Full Text] [Related]
19. Risk factor analysis and nomogram development and verification for medullary carcinoma of the colon using SEER database.
Yang L; Yu L; Zhou Q; Liu L; Shen N; Li N
Sci Rep; 2024 May; 14(1):11426. PubMed ID: 38763982
[TBL] [Abstract] [Full Text] [Related]
20. Dynamic radiological features predict pathological response after neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma.
Ruan Y; Ma Y; Ma M; Liu C; Su D; Guan X; Yang R; Wang H; Li T; Zhou Y; Ma J; Zhang Y
J Transl Med; 2024 May; 22(1):471. PubMed ID: 38762454
[TBL] [Abstract] [Full Text] [Related]
[Next]
